Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2005 Aug;20(4):586-90.
doi: 10.3346/jkms.2005.20.4.586.

Effect of high dose inhaled glucocorticoids on quality of life in patients with moderate to severe asthma

Jae-Sung Choi  1 , An-Soo Jang, June-Hyuk Lee, Jong-Sook Park, Sung-Woo Park, Do-Jin Kim, Choon-Sik Park
Affiliations
Clinical Trial

Effect of high dose inhaled glucocorticoids on quality of life in patients with moderate to severe asthma

Jae-Sung Choi et al. J Korean Med Sci. 2005 Aug.

Abstract

Asthma is a chronic disorder that can place considerable restrictions on the physical, emotional, and social aspects of the lives of patients. Inhaled glucocorticoids (GCs) are the most effective controller therapy. The purpose of this study was to evaluate the effect of inhaled GCs on quality of life in patients with moderate to severe asthma. Patients completed the asthma quality of life questionnaire (AQLQ) and pulmonary function test at baseline and after 4 wks treatment of GCs. We enrolled 60 patients who had reversibility in FEV1 after 200 microgram of albuterol of 15% or more and/or positive methacholine provocation test, and initial FEV1% predicted less than 80%. All patients received inhaled GCs (fluticasone propionate 1,000 microgram/day) for 4 wks. The score of AQLQ was significantly improved following inhaled GCs (overall 51.9+/-14.3 vs. 67.5+/-12.1, p<0.05). The change from day 1 to day 28 in FEV1 following inhaled GCs was diversely ranged from -21.0% to 126.8%. The improvement of score of AQLQ was not different between at baseline and after treatment of GCs according to asthma severity and GCs responsiveness. Quality of life was improved after inhaled GCs regardless of asthma severity and GCs responsiveness in patients with moderate to severe asthma.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The changes of AQLQ scores after inhaled glucocorticoids for 4wks in moderate to severe patients with asthma. A; baseline, B; 4 weeks, *p<0.05 compared with baseline values.
Fig. 2
Fig. 2
Change in overall AQLQ scores between responder and non-responder after inhaled glucocorticoids for 4 wks.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Global Initiative for Asthma (GINA) Global strategy for asthma management and prevention. NHLBI/WHO workshop report. Bethesda, Md: National Institutes of Health National Heart, Lung, and Blood Institute; 2002. NIH publication no. 02-3659. J Allergy Clin Immunol. 2002;110:S141–S219. - PubMed
    1. Blaiss MS. Outcomes analysis in asthma. JAMA. 1997;278:1874–1880. - PubMed
    1. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118:622–629. - PubMed
    1. Juniper EF. Quality of life in adults and children with asthma and rhinitis. Allergy. 1997;52:971–977. - PubMed
    1. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med. 1995;332:868–875. - PubMed

Publication types

Substances